![Patrick Verheyen](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Patrick Verheyen
Direttore/Membro del Consiglio presso
The Bioindustry Association
Patrimonio netto: 7 300 $ in data 31/07/2026
Profilo
Patrick Verheyen is currently Director at The Bioindustry Association.
Formerly, Mr. Verheyen was Director at Cougar Biotechnology, Inc. in 2009, Independent Director at Cue Biopharma, Inc. from 2023 to 2026, and Global Head-Janssen Business Development at Johnson & Johnson from 2015 to 2021.
Mr. Verheyen completed graduate studies at Katholieke Universiteit Leuven.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 05/05/2026 | 272 ( 0% ) | 7 300 $ | 31/07/2026 |
Posizioni attive di Patrick Verheyen
| Società | Posizione | Inizio |
|---|---|---|
The Bioindustry Association
 The Bioindustry Association Miscellaneous Commercial ServicesCommercial Services Operates as a association to encourage and promote bioscience sector | Direttore/Membro del Consiglio | - |
Precedenti posizioni note di Patrick Verheyen
| Società | Posizione | Fine |
|---|---|---|
| CUE BIOPHARMA, INC. | Direttore/Membro del Consiglio | 29/05/2026 |
| JOHNSON & JOHNSON | Corporate Officer/Principal | 01/01/2021 |
Cougar Biotechnology, Inc. /Old/
 Cougar Biotechnology, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products for the treatment of cancer | Direttore/Membro del Consiglio | 13/07/2009 |
Formazione di Patrick Verheyen
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
90
Relazioni di 1° grado
5
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 5 |
|---|---|
Johnson & Johnson
 Johnson & Johnson Pharmaceuticals: MajorHealth Technology Operates as an investment holding company with interests in health care products | Health Technology |
Cougar Biotechnology, Inc. /Old/
Cougar Biotechnology, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products for the treatment of cancer | Health Technology |
Katholieke Universiteit Leuven
 Katholieke Universiteit Leuven Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Bioindustry Association
The Bioindustry Association Miscellaneous Commercial ServicesCommercial Services Operates as a association to encourage and promote bioscience sector | Commercial Services |
Cue Biopharma, Inc.
 Cue Biopharma, Inc. BiotechnologyHealth Technology Develops biopharmaceuticals | Health Technology |
